Vitamin Shoppe Inc. (NYSE:VSI) shares rose 1.9% during trading on Monday . The stock traded as high as $31.94 and last traded at $31.67, with a volume of 318,727 shares. The stock had previously closed at $31.08.

VSI has been the topic of several analyst reports. William Blair lowered Vitamin Shoppe to a “market perform” rating in a report on Monday, March 28th. Robert W. Baird reiterated a “hold” rating on shares of Vitamin Shoppe in a report on Tuesday, April 26th. Wedbush began coverage on shares of Vitamin Shoppe in a report on Wednesday, April 20th. They issued an “outperform” rating and a $39.00 price objective on the stock. Zacks Investment Research upgraded shares of Vitamin Shoppe from a “sell” rating to a “hold” rating and set a $32.00 price objective on the stock in a report on Friday, May 6th. Finally, Jefferies Group restated a “hold” rating and issued a $32.00 price objective (up from $30.00) on shares of Vitamin Shoppe in a report on Friday, May 6th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $32.82.

The company has a market capitalization of $757.59 million and a price-to-earnings ratio of 18.12. The company has a 50-day moving average price of $30.71 and a 200 day moving average price of $29.99.

Vitamin Shoppe (NYSE:VSI) last posted its quarterly earnings data on Wednesday, May 4th. The company reported $0.67 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.02. The company had revenue of $336.80 million for the quarter, compared to analyst estimates of $339.76 million. During the same period in the previous year, the business earned $0.63 EPS. The firm’s revenue was up .0% on a year-over-year basis. On average, analysts predict that Vitamin Shoppe Inc. will post $2.32 EPS for the current year.

In related news, Director Guillermo Marmol acquired 1,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 31st. The shares were acquired at an average price of $30.23 per share, with a total value of $30,230.00. Following the completion of the purchase, the director now directly owns 1,470 shares in the company, valued at $44,438.10. The purchase was disclosed in a document filed with the SEC, which is available through this link.

Several hedge funds recently bought and sold shares of VSI. California State Teachers Retirement System raised its stake in Vitamin Shoppe by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 55,107 shares of the company’s stock worth $1,802,000 after buying an additional 885 shares during the last quarter. Rhumbline Advisers raised its stake in Vitamin Shoppe by 4.3% in the fourth quarter. Rhumbline Advisers now owns 45,118 shares of the company’s stock worth $1,475,000 after buying an additional 1,855 shares during the last quarter. Gabelli Funds LLC raised its stake in Vitamin Shoppe by 15.2% in the fourth quarter. Gabelli Funds LLC now owns 53,040 shares of the company’s stock worth $1,734,000 after buying an additional 7,000 shares during the last quarter. State of Wisconsin Investment Board raised its stake in Vitamin Shoppe by 0.8% in the fourth quarter. State of Wisconsin Investment Board now owns 159,102 shares of the company’s stock worth $5,203,000 after buying an additional 1,229 shares during the last quarter. Finally, Olstein Capital Management L.P. raised its stake in Vitamin Shoppe by 22.9% in the fourth quarter. Olstein Capital Management L.P. now owns 472,000 shares of the company’s stock worth $15,434,000 after buying an additional 88,000 shares during the last quarter.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.